Monthly Archives: June 2017

Earnings Review and Free Research Report: Ferrellgas Reported Q3 FY17 Earnings Results

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Ferrellgas Partners, L.P. (NYSE: FGP), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=FGP, following the Company’s posting of its financial results for the third quarter fiscal 2017 (Q3 FY17) on June 09, 2017. The Overland Park, Kansas-based Company’s total revenue grew on a year-over-year basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member’s account at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on FGP. With the links below you can directly download the report of your stock of interest free of charge at: http://protraderdaily.com/optin/?symbol=FGP.

Earnings Reviewed

In Q3 FY17, Ferrellgas total revenue increased to $538.11 million from $509.47 million recorded at the end of Q3 FY16. However, total revenue numbers for Q3 FY17 lagged behind market consensus estimates of $573 million.

Ferrellgas reported common unit-holders’ interest in net earnings of $6.47 million, or $0.07 per diluted common unit-holders’ interest, in Q3 FY17 compared to common unit-holders’ interest in net earnings of $18.50 million, or $0.19 per diluted common unit-holders’ interest, in Q3 FY16. Wall Street had estimated the Company to report net earnings of $0.10 per common unit-holders’ interest.

Operating Metrics

During the reported quarter, the Company reported gross profit of $201.05 million compared to $244.16 million in the prior year’s same period. Ferrellgas’ operating expense was down to $104.77 million from $115.14 million in the previous year’s same quarter. For Q3 FY17, general and administrative expense came in at $9.98 million versus $12.35 million in Q3 FY16. Furthermore, the Company’s operating income for Q3 FY17 was $46.20 million compared to $54.22 million reported in the prior quarter.

For Q3 FY17, the Company’s EBITDA was $71.94 million compared to $92.67 million in last year’s corresponding quarter. Furthermore, the Company’s adjusted EBITDA fell to $76.79 million in Q3 FY17 from $107.99 million in Q3 FY16, primarily due to decreased contributions from the midstream operations segment.

Revenue Segmentation

The Company’s Propane and other gas liquids sales came in at $369.44 million in Q3 FY17 compared to $338.93 million in the prior year’s same quarter. Propane gallons sales for Q3 FY17 were 212.22 million gallons compared to 223.36 million a year ago. Operating income from propane operations and related equipment sales segment came in at $67.12 million in Q3 FY17 compared to $78.72 million in the previous year’s same period. Furthermore, the segment’s adjusted EBITDA for the reported quarter came in at $86.99 million versus $96.34 million in Q3 FY16.

Ferrellgas’ revenues from Midstream operations increased to $126.68 million in Q3 FY17 from $105.42 million in Q3 FY16. The segment reported operating loss of $5.70 million in Q3 FY17 compared to operating loss of $0.76 million in Q3 FY16. The segment posted negative EBITDA of $0.55 million in Q3 FY17 against positive EBITDA of $23.33 million in Q3 FY16.

Cash Flow and Balance Sheet

During the nine months ended April 30, 2017, net cash provided by operating activities was $118.33 million compared to $220.08 million in the last year’s comparable period. As on April 30, 2017, the Company had cash and cash equivalents balance of $9.51 million compared to $4.97 million as on July 31, 2016. Furthermore, the Company reported long-term debt amounting to $1.98 billion as on April 30, 2017, versus $1.94 billion as on July 31, 2016. Furthermore, the Company’s consolidated leverage ratio stood at 6.45 times at the end of the reported quarter, which was lower than the 7.75 times limit allowed under the recently amended secured credit facility.
Stock Performance

At the close of trading session on Wednesday, June 28, 2017, Ferrellgas Partners’ stock price slipped 1.02% to end the day at $4.83. A total volume of 190.79 thousand shares were exchanged during the session. The Company’s shares have a dividend yield of 8.28%. At Wednesday’s closing price, the stock’s net capitalization stands at $471.21 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the ”Author”) and is fact checked and reviewed by a third party research service company (the ”Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the ”Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467076

Earnings Review and Free Research Report: H&R Block’s Quarterly EPS Surged 17%; Raised Dividend By 9%

Research Desk Line-up: Liberty Tax Post Earnings Coverage

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on H&R Block, Inc. (NYSE: HRB), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=HRB, following the Company’s announcement of its fourth quarter and fiscal 2017 financial results on June 13, 2017. The tax preparer surpassed top- and bottom-line expectations. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member’s account at: http://protraderdaily.com/register/.

Get more of our free earnings reports coverage from other constituents of the Personal Services industry. Pro-TD has currently selected Liberty Tax, Inc. (NASDAQ: TAX) for due-diligence and potential coverage as the Company reported on June 14, 2017, its financial results for fiscal year 2017. Register for a free membership today, and be among the early birds that get access to our report on Liberty Tax when we publish it.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on HRB; also brushing on TAX. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/?symbol=HRB

http://protraderdaily.com/optin/?symbol=TAX

Earnings Reviewed

For the three months ended April 30, 2017, H&R Block’s revenue totaled $2.33 billion compared to revenue of $2.30 billion in Q4 FY16. The Company’s revenue numbers surpassed analysts’ consensus of $2.32 billion.

For FY17, H&R Block’s revenues were almost flat on a y-o-y basis to $3.03 billion as improvement in the Company’s assisted net average charge was partially offset by a decline in return volume. DIY tax preparation revenue declined as H&R Block More ZeroSM promotion resulted in a lower net average charge which was partially offset by increased return volume.

During Q4 FY17, H&R Block’s operating expenses came in at $818.81 million compared to $853.13 million in Q4 FY16. For FY17, the Company’s operating expenses decreased 3.5% to $1.64 billion, driven by cost reduction measures which led to lower compensation and benefits and marketing costs, along with lower bad debt expense due to more favorable collections on prior year’s receivables.

H&R Block’s net income came in at $783.35 million, or $3.75 per diluted share, compared to net income of $700.66 million, or $$3.13 per diluted share, in Q4 FY16. Earnings, adjusted to account for discontinued operations and non-recurring costs, totaled $3.76 per share, beating Wall Street’s estimates of $3.51 per share.

For FY17, H&R Block’s net income from continuing operations increased 10% to $421 million, while diluted earnings per share from continuing operations increased $0.43, or 28%, to $1.96. In the reported year, H&R Block’s EBITDA from continuing operations improved 11% to $904 million. The Company’s EBITDA margin totaled 29.8% for the reported quarter, an improvement of over 300 basis points from the prior fiscal year.

Cash Matters

H&R Block ended the fiscal year with $1.0 billion in unrestricted cash compared to $0.9 billion the prior year.

During fiscal 2017, H&R Block repurchased and retired approximately 14 million shares at an aggregate amount of $317 million, or $22.61 per share under a $3.5 billion share repurchase program approved by the Company’s Board of Directors in August 2015 and effective through June 2019. Under this program, H&R Block has repurchased a total of approximately 70.4 million shares of its common stock, or approximately 25% of outstanding shares, since the inception of the program, for an aggregate purchase amount of approximately $2.3 billion.

As of April 30, 2017, H&R Block had 207.2 million shares outstanding.

H&R Block announced that its Board of Directors approved an increase in its quarterly dividend of 9% to $0.24 per share. The dividend is payable on July 03, 2017, to shareholders of record as of June 23, 2017. H&R Block has paid quarterly dividends consecutively since the Company went public in 1962.

Leadership Transition

On May 16, 2017, H&R Block announced that Bill Cobb, President and Chief Executive Officer, will retire from the Company and the H&R Block’s Board of Directors effective July 31, 2017. The Company’s Board of Directors has appointed Tom Gerke, currently the General Counsel and Chief Administrative Officer, to be the interim President and CEO beginning August 01, 2017. H&R Block’s Board has retained a search firm to assist in the search for a permanent President and CEO.

Stock Performance

At the closing bell, on Wednesday, June 28, 2017, H&R Block’s stock dropped 1.91%, ending the trading session at $30.74. A total volume of 6.67 million shares have exchanged hands, which was higher than the 3-month average volume of 3.21 million shares. The Company’s stock price skyrocketed 34.65% in the last three months, 30.75% in the past six months, and 37.72% in the previous twelve months. Moreover, the stock soared 33.71% since the start of the year. The stock is trading at a PE ratio of 15.40 and has a dividend yield of 3.12%. The stock currently has a market cap of $6.37 billion.

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467075

Corporate News Blog – Google’s Comparison Shopping Service under Scrutiny; Faces $2.7 Billion Fine from the European Antitrust Commission

Research Desk Line-up: Fang Holdings Post Earnings Coverage

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=GOOGL. The European Commission announced on June 27, 2017, that it has fined Google, an Alphabet, Inc.’s (NASDAQ: GOOGL) (NASDAQ: GOOG) subsidiary, about $2.7 billion for breaching EU antitrust rules. According to the ruling, Google abused its market dominance as a search engine, and the gateway to the internet, by offering an illegal advantage to another Google product, under its comparison shopping service. Currently, 90% of Google’s revenues are generated from adverts that it shows consumers in response to a search query. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

Discover more of our free reports coverage from other companies within the Internet Information Providers industry. Pro-TD has currently selected Fang Holdings Limited (NYSE: FANG) for due-diligence and potential coverage as the Company announced on June 20, 2017, its unaudited financial results for Q1 2017 which ended on March 31, 2017. Tune in to our site to register for a free membership, and be among the early birds that get our report on Fang Holdings when we publish it.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on GOOGL; also brushing on FANG. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=GOOGL

http://protraderdaily.com/optin/?symbol=FANG

The Case

In 2004, Google entered the separate market of comparison shopping in Europe, where it launched a product, initially known as Froogle. The product was later renamed as “Google Product Search” in 2008, and eventually in 2013, the product was called “Google Shopping”. Google Shopping allows consumers to compare products and prices online and find the best deal from different online retailers.

From 2008, owing to the number of established players in the market, Google began to implement in European markets a fundamental change in strategy to steer its comparison shopping service. The strategy relied primarily on Google’s dominance in general internet search, rather than competition on the merits of comparing shopping markets. According to the EU antitrust regulation, Google has systematically given prominent placement to its own comparison shopping service. Also, Google demoted rival comparison shopping services in its search results, on the basis of Google’s generic search algorithms. As a consequence, Google’s comparison shopping service is much more visible to consumers in Google’s search results, while the rival comparison shopping services are much less accessible.

The Probe

In November of 2009, Foundem, a UK price-comparison website, filed a complaint in Brussels over Google’s search practices. Later in November 2010, EU regulators began a formal investigation into Google’s search practices. Google then submitted proposals in 2013 to address concerns it favored under its own search services, struck restrictive deals with advertisers, and copied content from rival websites without permission.

Later, in February 2014, after further concessions by Google, Brussels announced a settlement. However, in April 2015, the EU announced formal charge against Google for the first time, accusing the search giant of skewing results to favor its shopping service. This ruling from the European Commission signifies a major outlook if Google, the Internet-gateway, harnessed its dominance in the markets, spanning from online ads to mobile-phone software as a medium to promote its own services, at the expense of its competitors.

A New Chapter

This ruling marks a new era into how tech-giants promote their services, and offer consumers their products. This fine could just be the first in a series of EU antitrust penalties for Google, which is fighting on at least two other fronts – its Android mobile-phone software and the AdSense online advertising service.

Market Dominance by itself is not illegal under antitrust rules, but Companies with a market leading position have the liability not to abuse their position by restricting competition, be it in the market where they are dominant or in separate markets.

Google now has nine days to end the abuse or face penalty payments of up to 5% of the average daily worldwide turnover of Alphabet.

Last Close Stock Review

At the closing bell, on Wednesday, June 28, 2017, Alphabet’s stock climbed 1.36%, ending the trading session at $961.01. A total volume of 2.74 million shares have exchanged hands, which was higher than the 3-month average volume of 1.65 million shares. The Company’s stock price soared 13.08% in the last three months, 18.65% in the past six months, and 39.02% in the previous twelve months. Moreover, the stock surged 21.27% since the start of the year. The stock is trading at a PE ratio of 30.98 and currently has a market cap of $659.58 billion.

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467090

Dividend Coverage: This Defense Contractor Has Increased Dividend for the Past 12 Years; Will Trade Ex-Dividend on June 30, 2017

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily takes a closer look at Raytheon Co. (NYSE: RTN) as the Company’s stock will begin trading ex-dividend on June 30, 2017. In order to capture the dividend payout, investors must purchase the stock one day prior to the ex-dividend date that is by latest end of the trading session on June 29, 2017. Are you looking for research on dividend stocks, if so register with us now for your free membership at:

http://protraderdaily.com/register/

Today, PRO-TD covers ex-dividend news on RTN. Get our free coverage by signing up at:

http://protraderdaily.com/optin/?symbol=RTN

Dividend Declared

On May 25, 2017, Raytheon announced that its Board of Directors has declared a quarterly cash dividend of $0.7975 per outstanding share of common stock. The cash dividend is payable on August 03, 2017, to shareholders of record as of the close of business on July 05, 2017.

Raytheon’s indicated dividend represents a yield of 1.96%, which is higher compared to the average dividend yield of 1.62% for the industrial goods sector. The Company has increased its dividend consecutively for the past 12 years.

Dividend Insights

Raytheon has a dividend payout ratio of 42.6%, which reflects that the Company distributes approximately $0.43 for every $1.00 earned. The dividend payout ratio reflects how much money a Company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, or to add to its cash reserves.

According to analysts’ estimates, Raytheon is expected to report earnings of $8.80 in the coming year, which again comfortably covers the Company’s annualized dividend of $3.19.

As on April 02, 2017 Raytheon had cash and cash items worth $2.19 billion and its current assets totaled $10.52 billion, while current liabilities were $6.31 billion. The strong financial position would allow the Company to absorb any fluctuations in earnings and pay its dividend without interruption.

About the Company

Raytheon Company, with 2016 sales of $24 billion and 63,000 employees, is a technology and innovation leader specializing in defense, civil government, and cybersecurity solutions. With a history of innovation spanning 95 years, Raytheon provides state-of-the-art electronics, mission systems integration, C5I™ products and services, sensing, effects, and mission support for customers in more than 80 countries. Raytheon is headquartered in Waltham, Massachusetts.

Recent Development for Raytheon

On June 26, 2017, Raytheon and the US Army Apache Program Management Office, in collaboration with US Special Operations Command, recently completed a successful flight test of a high energy laser system onboard an Apache AH-64 at White Sands Missile Range, New Mexico. The demonstration marks the first time that a fully integrated laser system successfully engaged and fired at a target from a rotary-wing aircraft over a wide variety of flight regimes, altitudes and air speeds.

The test achieved all primary and secondary goals, providing solid experimental evidence for the feasibility of high resolution, multi-band targeting sensor performance and beam propagation supportive of High Energy Laser capability for the rotary-wing attack mission.

“Our goal is to pull the future forward,” said Art Morrish, Vice President of Advanced Concept and Technologies for Raytheon Space and Airborne Systems, “This data collection shows we’re on the right track. By combining combat proven sensors, like the MTS, with multiple laser technologies, we can bring this capability to the battlefield sooner rather than later.”

Stock Performance

On Wednesday, June 28, 2017, the stock closed the trading session at $162.55, slightly climbing 0.86% from its previous closing price of $161.16. A total volume of 841.80 thousand shares have exchanged hands. Raytheon’s stock price surged 6.99% in the last three months, 13.61% in the past six months, and 22.23% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have rallied 14.47%. The stock is trading at a PE ratio of 20.98 and has a dividend yield of 1.96%. At Wednesday’s closing price, the stock’s net capitalization stands at $48.03 billion.

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467083

Corporate News Blog – Aralez Announced District Court Decision to Uphold VIMOVO Patents

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=ARLZ. The Company announced on June 27, 2017, that the United States District Court for the District of New Jersey upheld the validity of two patents owned by a subsidiary of Aralez and licensed to Horizon Pharma PLC, over VIMOVO (naproxen/esomeprazole magnesium). The dispute arose over the case that Dr. Reddy’s, Lupin, or Mylan would infringe at least one of the two patents, with their proposed generic naproxen/esomeprazole magnesium products. For immediate access to our complimentary reports, including today’s coverage, register for free now at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on ARLZ. Go directly to your stock of interest and access today’s free coverage at: http://protraderdaily.com/optin/?symbol=ARLZ.

The Announcement

This upholds of validity of the two patents follows the patent infringement lawsuits filed by an Aralez’s subsidiary on April 21, 2011, July 25, 2011, and June 28, 2013, in District Court against Dr. Reddy’s, Lupin, and Mylan, respectively, related to the Abbreviated New Drug Applications (ANDA) filed with the FDA to market generic versions of VIMOVO. The lawsuits filed denotes infringement claim of US Patent Nos. 8,557,285 (‘285 patent) and 6,926,907 (‘907 patent) titled “Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs,” which cover VIMOVO. The District Court’s decision was made based on the validity of the ‘285 and ‘907 patents for VIMOVO and the Court’s judgment will prevent Dr. Reddy’s, Mylan, and Lupin from launching generic versions of VIMOVO in the United States until at least the expiration of the relevant patent.

The Company views this announcement as a fair and appropriate ruling regarding the litigation. The Company stated that the ruling demonstrates the strength of its portfolio of VIMOVO and Yosprala, while it remains committed aggressively to defend its intellectual property portfolio.

What is VIMOVO?

VIMOVO is a fixed combination of naproxen, a non-steroidal anti-inflammatory drug, and esomeprazole, a proton pump inhibitor (PPI) indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. The drug decreases the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. The drug VIMOVO is not interchangeable with the individual components of naproxen and esomeprazole magnesium.

VIMOVO currently has 14 Orange Book listed patents with terms that exceed up to 20131. The ‘907 patent is also listed in the Orange Book for Yosprala (aspirin/omeprazole) and has been asserted against Teva Pharmaceuticals US, Inc., (NYSE: TEVA) in a separate patent infringement case.

Company Growth Prospects

Aralez recently announced on June 07, 2017, the national commercial launch of Zontivity (vorapaxar) in the US. Zontivity is the only antiplatelet therapy that inhibits PAR-1 mediated platelet aggregation in response to thrombin. Zontivity is a once-daily agent indicated for the reduction of thrombotic CV events in patients with a history of myocardial infarction in patients with the peripheral arterial disease. This announcement came on the heels of the commencement of phased launch of Zontivity on April 24, 2017, utilizing 15 sales representatives deployed to high volume physicians who treat post-MI and PAD patients.

On May 09, 2017, the Company announced its guidance as it expects net revenues to be in the range of $80 million to $100 million for the year ending December 31, 2017.

Last Close Stock Review

At the close of trading session on Wednesday, June 28, 2017, Aralez Pharma’s stock price rose 1.50% to end the day at $1.35. A total volume of 364.56 thousand shares were exchanged during the session. The Company’s shares advanced 8.00% in the last one month. At Wednesday’s closing price, the stock’s net capitalization stands at $83.54 million.

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467080

USMJ Announces Make America 420 Friendly Again Fourth of July Rally

DALLAS, TX / ACCESSWIRE / June 29, 2017 / North American Cannabis Holdings, Inc. (OTC PINK: USMJ) today announced a Fourth of July Holiday Season Social Media Campaign to Rally Support for Marijuana Legalization. The Company is encouraging legalization supporters to re-post the picture below through their favorite social media apps to demonstrate national solidarity for Making America 420 Friendly Again.

North American Cannabis Holdings, widely known as “USMJ” was founded by military veterans. The Company’s mission is to support cannabis entrepreneurs by connecting entrepreneurs with anybody and everybody interested in investing one dollar to a million dollars in the future of legal cannabis. USMJ brings entrepreneurs and investors together through partnership in micro-cap public companies traded on the OTC Markets. Investors can buy micro-cap public stock in public holding companies under which entrepreneurs build their cannabis enterprises. Stock purchases help the entrepreneurs get access to investment capital, and if the entrepreneurs have success, investors can enjoy the stock price reaction to the entrepreneurs’ success.

USMJ is publicly traded on the OTC Markets and has piloted a variety of entrepreneurial cannabis enterprises. One pilot is now listed on the OTC Markets in a standalone public holding company – Puration, Inc. (PURA) – a cannabis extraction company.

Invest In Entrepreneurial Cannabis Enterprises To Make America 420 Friendly Again

Dozens of entrepreneurial cannabis enterprises are racing toward the future of legal cannabis sourcing investment capital by operating under an OTC Markets listed public holding company. Rocky Mountain High Brands (RMHB) is making cannabis infused beverages. PotNetwork Holdings (POTN) can’t keep cannabis infused gummies in stock. HEMP, Inc. (HEMP) is building out an industrial hemp processing facility. MassRoots (MSRT) is helping cannabis consumers make educated purchasing decisions. Spend some time this Fourth of July Holiday Season Google Searching on entrepreneurial cannabis enterprises publicly traded on the OTC Markets. Find one or two or more that you like and get behind the entrepreneurs.

Contact:

North American Cannabis Holdings, Inc.
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com

SOURCE: North American Cannabis Holdings, Inc.

ReleaseID: 467109

Report Coverage on Technology Stocks: BlackBerry, Sandvine, Total Telcom, and Mitel Networks

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Communication Equipment industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: BlackBerry, Sandvine, Total Telcom, and Mitel Networks. Register for these free reports at:

http://protraderdaily.com/register/

On Wednesday, June 28, 2017, the Toronto Exchange Composite Index was up 0.49%, finishing the day at 15,355.58. The TSX Venture Composite Index, on the other hand, closed at 769.50, down 0.05%.

Additionally, the Technology index was slightly up by 0.03%, ending the session at 62.68.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: BlackBerry Ltd (TSX: BB), Sandvine Corporation (TSX: SVC), Total Telcom Inc. (TSX-V: TTZ), and Mitel Networks Corporation (TSX: MNW). Sign up now for your free membership and research reports at:

http://protraderdaily.com/register/

BlackBerry Ltd

Waterloo, Canada headquartered BlackBerry Ltd’s stock advanced 1.60%, to finish Wednesday’s session at $13.35 with a total volume of 2.13 million shares traded. Over the last three months and the previous one year, BlackBerry Ltd’s shares have surged 42.63% and 53.98%, respectively. Shares of the Company, which operates as security software and services company in securing, connecting, and mobilizing enterprises worldwide, are trading above its 200-day moving average. BlackBerry’s 50-day moving average of $14.19 is above its 200-day moving average of $11.14. See our research report on BB.TO at:

http://protraderdaily.com/optin/?symbol=BB

Sandvine Corp.

On Wednesday, shares in Waterloo, Canada headquartered Sandvine Corp. recorded a trading volume of 4.80 million shares, which was above their three months average volume of 655,904 shares. The stock ended the day 8.95% higher at $4.26. Sandvine’s stock has gained 10.36% in the last one month and 39.22% in the previous three months. Furthermore, the stock has surged 64.25% in the previous one year. The Company’s shares are trading above its 50-day and 200-day moving averages. The company stock’s 50-day moving average of $3.62 is above its 200-day moving average of $3.09. Shares of the Company, which researches, designs, develops, manufactures, and markets network policy control solutions for fixed, mobile, and converged communications service providers worldwide, are trading at a PE ratio of 50.71. The complimentary research report on SVC.TO at:

http://protraderdaily.com/optin/?symbol=SVC

Total Telcom Inc

On Wednesday, shares in Kelowna, Canada headquartered Total Telcom Inc. ended the session 2.50% higher at $0.21 with a total volume of 20,000 shares traded. Total Telcom’s shares have rallied 310.00% in the past one year. The stock is trading above its 200-day moving average. Furthermore, the stock’s 50-day moving average of $0.22 is greater than its 200-day moving average of $0.19. Shares of Total Telcom, which through its subsidiary, ROM Communications Inc., develops and provides Web to wireless products and services for commercial, industrial, and consumer applications in North America, are trading at a PE ratio of 14.64. Register for free and access the latest research report on TTZ.V at:

http://protraderdaily.com/optin/?symbol=TTZ

Mitel Networks Corp.

Ottawa, Canada headquartered Mitel Networks Corp.’s stock closed the day 0.74% higher at $9.53. The stock recorded a trading volume of 83,967 shares. Mitel Networks’ shares have advanced 0.85% in the last one month and 2.25% in the past three months. Furthermore, the stock has gained 17.51% in the previous one year. Shares of the Company, which provides business communications and collaboration software, services, and solutions in the Americas, Europe, Middle-East, Africa, and Asia/Pacific regions, are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $9.48 is greater than its 200-day moving average of $9.29. Get free access to your research report on MNW.TO at:

http://protraderdaily.com/optin/?symbol=MNW

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467097

Corporate News Blog – Regeneron and Sanofi Announced Kevzara Approval by the European Commission

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=REGN. Regeneron Pharma and Sanofi (NYSE: SNY) announced on June 27, 2017, that the European Commission has granted marketing authorization for Kevzara (sarilumab) in combination with methotrexate (MTX) for the treatment of moderately to severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs), like MTX. Kevzara, according to Regeneron, can be used as monotherapy in case of intolerance to MTX, or when treatment with methotrexate is inappropriate. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on REGN and SNY. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=REGN

Rheumatoid Arthritis

RA is a difficult-to-treat, lifelong disease, where many healthcare providers are challenged with finding a treatment that works for their patients. RA affects about 2.9 million people in Europe itself, where in the immune system it attacks the tissues of the joints, causing inflammation, joint pain, swelling, stiffness, fatigue and eventually joint damage and disability, and is most common in those aged between 35 to 50 years old.

Kevzara is indicated for the treatment of adult patients with moderately to severely active RA, who have had an inadequate response to one or more DMARDs. Kevzara is a human monoclonal antibody that binds to the interleukin-6 receptor (IL-6R) and blocks pro-inflammatory IL-6 mediated signaling. Patients with RA usually have elevated levels of IL-6 in their synovial fluid, where both pathologic inflammation and joint destruction are hallmarks of RA. Kevzara was developed using the Company’s proprietary VelocImmune technology that yields optimized full-human antibodies.

The EC Approval

The EC Approval based on a positive opinion by European Medicine Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), evaluated results from seven Phase-3 trials, in the global SARIL-RA clinical development program. The studies incorporate data from about 3,300 adults with moderately to severely active RA, who have had an inadequate response or intolerance to one or more biologic or non-biologic DMARDs.

In the Phase-3 MONARCH study, Kevzara 200 mg was indicated against adalimumab 40mg (also known as HUMIRA by AbbVie) monotherapy, where the former was observed in reducing disease activity and improving physical function, with more patients achieving clinical remission over 24 weeks. In Phase-study with Kevzara plus MTX, reduced signs and symptoms of RA were observed, with improved physical function. At week 52, it inhibited the progression of structural damage by 91% for the Kevzara 200 mg dose and 68% for Kevzara 150 mg dose, compared to placebo plus MTX.

The Delayed FDA Approval

Last year, in October 2016, Sanofi and Regeneron expected that at the end of the month, i.e., the PDUFA date, the Companies would get the US nod for its IL-6R contender in RA. However, the Companies were hit by a complete response letter from the FDA for manufacturing concerns, where experimental med sarilumab faced months of delay. According to the Companies, FDA disapproved the med over certain deficiencies identified during a routine good manufacturing practice inspection of the Sanofi Le Trait Facility. However, on May 22, 2017, after almost 7 months of delay, the Companies received FDA approval for sarilumab, paving the path for future development and eligibility for manufacturing and sales of sarilumab in the US.

Last Close Stock Review

At the closing bell, on Wednesday, June 28, 2017, Regeneron Pharma’s stock climbed 2.20%, ending the trading session at $513.19. A total volume of 932.79 thousand shares have exchanged hands. The Company’s stock price skyrocketed 30.20% in the last three months, 32.97% in the past six months, and 51.04% in the previous twelve months. Moreover, the stock soared 39.80% since the start of the year. The stock is trading at a PE ratio of 61.74 and currently has a market cap of $54.08 billion.

Sanofi’s share price finished yesterday’s trading session flat at $49.29. A total volume of 830.26 thousand shares have exchanged hands. The Company’s stock price surged 8.88% in the last three months, 24.19% in the past six months, and 21.55% in the previous twelve months. Additionally, the stock rallied 21.88% since the start of the year. Shares of the Company have a PE ratio of 24.29 and have a dividend yield of 3.33%. The stock currently has a market cap of $120.69 billion.

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467093

Research Initiated on Real Estate Stocks: American Hotel Income Properties REIT, Killam Apartment REIT, Slate Office REIT, and Choice Properties REIT

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the REITs industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: American Hotel Income Properties REIT, Killam Apartment REIT, Slate Office REIT, and Choice Properties REIT. Register for these free reports at:

http://protraderdaily.com/register/

On Wednesday, June 28, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,355.58, 0.49% higher, with a total volume of 280,259,421 shares.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: American Hotel Income Properties REIT L.P. (TSX: HOT-UN), Killam Apartment Real Estate Investment Trust (TSX: KMP-UN), Slate Office REIT (TSX: SOT-UN), and Choice Properties Real Estate Investment Trust (TSX: CHP-UN). Sign up now for your free membership and research reports at:

http://protraderdaily.com/register/

American Hotel Income Properties REIT L.P.

Vancouver, British Columbia-based American Hotel Income Properties REIT L.P.’s stock fell 1.09%, to finish Wednesday’s session at $9.94 with a total volume of 276,058 shares traded. American Hotel Income Properties REIT’s shares have advanced 0.75% in the past one year. The Company’s shares are trading below its 50-day and 200-day moving averages. American Hotel Income Properties REIT’s 200-day moving average of $10.54 is above its 50-day moving average of $10.43. Shares of the Company, which invests in the real estate markets across US, are trading at a PE ratio of 35.25. See our research report on HOT-UN.TO at:

http://protraderdaily.com/optin/?symbol=HOT.UN

Killam Apartment Real Estate Investment Trust

On Wednesday, shares in Killam Apartment Real Estate Investment Trust, which owns, manages and develops multi-family residential properties in across Canada and operates MHC communities in Ontario and Eastern Canada, recorded a trading volume of 108,121 shares during the session. The stock ended the day 0.94% higher at $13.00. The complimentary research report on KMP-UN.TO at:

http://protraderdaily.com/optin/?symbol=KMP.UN

Slate Office REIT

On Wednesday, shares in Toronto, Canada headquartered Slate Office REIT ended the session 0.62% lower at $8.08 with a total volume of 105,657 shares traded. Slate Office REIT’s shares have gained 1.91% in the last three months and 15.50% in the previous one year. The stock is trading above its 200-day moving average. Furthermore, the stock’s 50-day moving average of $8.10 is greater than its 200-day moving average of $8.07. Shares of Slate Office, which focuses on the ownership and acquisition of industrial, office, and retail real estate primarily in Canada, are trading at a PE ratio of 9.03. Register for free and access the latest research report on SOT-UN.TO at:

http://protraderdaily.com/optin/?symbol=SOT.UN

Choice Properties Real Estate Investment Trust

Toronto, Ontario-based Choice Properties Real Estate Investment Trust’s stock closed the day 1.45% higher at $14.14. The stock recorded a trading volume of 89,806 shares, which was above its three months average volume of 51,889 shares. Choice Properties REIT’s shares have advanced 2.18% in the last one month and 3.44% in the past three months. Furthermore, the stock has gained 4.84% in the previous one year. Shares of the Company, which invests in the real estate markets of Canada, are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $13.95 is greater than its 200-day moving average of $13.86. Get free access to your research report on CHP-UN.TO at:

http://protraderdaily.com/optin/?symbol=CHP.UN

—

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467099

Daily Coverage on Financials Stocks: Manulife Financial, Power Financial, Great West Lifeco, and Intact Financial

LONDON, UK / ACCESSWIRE / June 29, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Insurance – Life/ Property & Casualty industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Manulife Financial, Power Financial, Great-West Lifeco, and Intact Financial. Register for these free reports at:

http://protraderdaily.com/register/

At the close of the Canadian markets on Wednesday, June 28, 2017, the Toronto Exchange Composite Index ended the trading session at 15,355.58, 0.49% higher from its previous closing price.

The Financials Index was also in the black, closing the day at 286.02, up 0.94%.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: Manulife Financial Corporation (TSX: MFC), Power Financial Corporation (TSX: PWF), Great-West Lifeco Inc. (TSX: GWO), and Intact Financial Corporation (TSX: IFC). Sign up now for your free membership and research reports at:

http://protraderdaily.com/register/

Manulife Financial Corp.

Toronto, Canada headquartered Manulife Financial Corp.’s stock advanced 1.56%, to finish Wednesday’s session at $24.08 with a total volume of 4.03 million shares traded. Over the last one month and the previous three months, Manulife Financial’s shares have advanced 1.82% and 2.18%, respectively. Furthermore, the stock has gained 41.23% in the past one year. Shares of the Company, which together with its subsidiaries, provides financial advice, insurance, and wealth and asset management solutions for individuals, groups, and institutions in Asia, Canada, and the US, are trading above its 50-day and 200-day moving averages. Manulife Financial’s 200-day moving average of $24.07 is above its 50-day moving average of $23.73. See our research report on MFC.TO at:

http://protraderdaily.com/optin/?symbol=MFC

Power Financial Corp.

On Wednesday, shares in Montréal, Canada headquartered Power Financial Corp. recorded a trading volume of 352,832 shares. The stock ended the day 0.95% higher at $33.28. Power Financial’s stock has gained 3.65% in the last one month and 17.85% in the previous one year. The Company’s shares are trading above its 50-day moving average. The stock’s 200-day moving average of $34.19 is above its 50-day moving average of $32.78. Shares of the Company, which provides financial services in Canada, the US, Europe, and Asia, are trading at a PE ratio of 11.10. The complimentary research report on PWF.TO at:

http://protraderdaily.com/optin/?symbol=PWF

Great-West Lifeco Inc.

On Wednesday, shares in Winnipeg, Canada-based Great-West Lifeco Inc. ended the session 0.93% higher at $34.84 with a total volume of 329,280 shares traded. Great-West Lifeco’s shares have advanced 3.08% in the last one month and 6.59% in the previous one year. Shares of the Company, which engages in life and health insurance, asset management, investment and retirement savings, and reinsurance businesses in Canada, the US, Europe, and Asia, are trading above its 50-day moving average. Furthermore, the stock’s 200-day moving average of $35.76 is greater than its 50-day moving average of $34.05. Register for free and access the latest research report on GWO.TO at:

http://protraderdaily.com/optin/?symbol=GWO

Intact Financial Corp.

Toronto, Canada-based Intact Financial Corp.’s stock closed the day 0.70% higher at $96.71. The stock recorded a trading volume of 89,422 shares. Intact Financial’s shares have advanced 4.64% in the last one month and 3.13% in the past three months. Furthermore, the stock has gained 7.56% in the previous one year. The Company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $94.42 is greater than its 50-day moving average of $93.70. Shares of the Company, which through its subsidiaries, provides property and casualty insurance products to individuals and businesses in Canada, are trading at a PE ratio of 24.61. Get free access to your research report on IFC.TO at:

http://protraderdaily.com/optin/?symbol=IFC

Pro-Trader Daily:

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

NO WARRANTY

NOT AN OFFERING

CONTACT

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute

SOURCE: Pro-Trader Daily

ReleaseID: 467102